ANDA 62816, held by Chartwell RX. Ampicillin Sodium.
As of Nov 21, 2026, ANDA 62816 (Ampicillin Sodium), held by Chartwell RX, was first approved by FDA on Oct 28, 1988, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 1988 | Original application | Approved | None posted |
| Ampicillin SodiumEQ 125MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Ampicillin SodiumEQ 250MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Ampicillin SodiumEQ 500MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Ampicillin SodiumEQ 1GM BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Ampicillin SodiumEQ 2GM BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Dec 8, 2000 | Supplement 22Manufacturing | Approved | None posted |
| Nov 8, 1999 | Supplement 21Manufacturing | Approved | None posted |
| Dec 29, 1997 | Supplement 20Manufacturing | Approved | None posted |
| Jul 30, 1997 | Supplement 19Manufacturing | Approved | None posted |
| Apr 17, 1996 | Supplement 18Manufacturing | Approved | None posted |
| Mar 12, 1996 | Supplement 17Labeling | Approved | None posted |
| Jun 23, 1995 | Supplement 16Manufacturing | Approved | None posted |
| Jan 27, 1995 | Supplement 15Manufacturing | Approved | None posted |
| Jan 13, 1994 | Supplement 14Manufacturing | Approved | None posted |
| Nov 19, 1993 | Supplement 13Manufacturing | Approved | None posted |
| Nov 9, 1993 | Supplement 12Manufacturing | Approved | None posted |
| Nov 9, 1993 | Supplement 11Manufacturing | Approved | None posted |
| Jan 23, 1991 | Supplement 4Manufacturing | Approved | None posted |
| Dec 26, 1990 | Supplement 9Labeling | Approved | None posted |
| Dec 7, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Nov 10, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Nov 8, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Oct 28, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters